GMC Domains
- THE DOCTOR AS A SCHOLAR
- TD 8: APPLICATION OF BIOMEDICAL SCIENTIFIC PRINCIPLES, METHOD AND KNOWLEDGE
- Medical knowledge: ANATOMY (TD 8.1)
- Medical knowledge: PHYSIOLOGY (TD 8.2)
- Medical knowledge: BIOCHEMISTRY (inc. Metabolism) (TD 8.3)
- Medical knowledge: CELL BIOLOGY (TD 8.4)
- Medical knowledge: MOLECULAR BIOLOGY and GENETICS (TD 8.5, 8.6)
- Medical knowledge: PATHOLOGY (TD 8.7)
- Medical knowledge: CANCER
- Medical knowledge: IMMUNOLOGY and INFLAMMATION (TD 8.8)
- Medical knowledge: MICROBIOLOGY and INFECTION (TD 8.9)
- Medical knowledge: PHARMACOLOGY (TD 8.10)
- Medical knowledge: NUTRITION (TD 8.11)
- Medical knowledge: CLINICAL FEATURES of DISEASE (TD 8 b)
- TD 9: APPLICATION OF PSYCHOLOGICAL PRINCIPLES, METHOD AND KNOWLEDGE
- TD 10: APPLICATION OF SOCIAL SCIENCE PRINCIPLES, METHOD AND KNOWLEDGE
- TD 11. PRINCIPLES, METHODS AND KNOWLEDGE OF POPULATION HEALTH
- TD 12; APPLICATION OF SCIENTIFIC METHOD AND APPROACHES TO MEDICAL RESEARCH
- TD 8: APPLICATION OF BIOMEDICAL SCIENTIFIC PRINCIPLES, METHOD AND KNOWLEDGE
- THE DOCTOR AS A PRACTITIONER
- TD 13: CARRY OUT A CONSULTATION WITH A PATIENT
- TD 14: DIAGNOSE AND MANAGE CLINICAL PRESENTATIONS
- Clinical skills: INTERPRETING FINDINGS AND INITIAL ASSESSMENT (TD 14 a-b)
- Clinical skills: PLANNING AND INTERPRETING INVESTIGATIONS (TD 14 c-d)
- Clinical skills: MAKING A DIAGNOSIS and CLINICAL JUDGEMENT (TD 14 e-f)
- Clinical skills: FORMULATING A TREATMENT PLAN (TD 14 g)
- Clinical skills: SURGERY and ANAESTHETICS (TD 14 g)
- Clinical skills: SUPPORTING PATIENTS and IDENTIFYING ABUSE and NEGLECT (TD 14 h-i)
- Clinical Skills: CARE OF PATIENTS AND RELATIVES AT END OF LIFE (TD 14 j)
- TD 15: COMMUNICATE EFFECTIVELY WITH PATIENTS AND COLLEAGUES
- TD 16: PROVIDE IMMEDIATE CARE IN MEDICAL EMERGENCIES
- TD 17: PRESCRIBE DRUGS SAFELY, EFFECTIVELY AND ECONOMICALLY
- TD 18: CARRY OUT PRACTICAL PROCEDURES SAFELY AND EFFECTIVELY
- TD 19: USE INFORMATION EFFECTIVELY IN A MEDICAL CONTEXT
- THE DOCTOR AS A PROFESSIONAL
- TD 20: BEHAVE ACCORDING TO ETHICAL AND LEGAL PRINCIPLES
- TD 21: REFLECT, LEARN AND TEACH OTHERS
- TD 22: LEARN AND WORK EFFECTIVELY WITHIN A MULT-PROFESSIONAL TEAM
- TD 23: PROTECT PATIENTS AND IMPROVE CARE
- Professional issues: DUTIES OF A DOCTOR (TD 23 a-b)
- Professional issues: MEDICAL FRAMEWORK IN THE UK (TD 23 c)
- Professional issues: RISK MANAGEMENT and PATIENT SAFETY (TD 23 d)
- Professional issues: GOVERNANCE, QUALITY MATTERS and AUDIT (TD 23 e)
- Professional issues: PERSONAL ATTITUDES and SELF CARE (TD 23 f-j)
TD 8: APPLICATION OF BIOMEDICAL SCIENTIFIC PRINCIPLES, METHOD AND KNOWLEDGE: Medical knowledge: IMMUNOLOGY and INFLAMMATION (TD 8.8)
Index
- Immunology
- Immunology - General Outcomes
- Appreciate that the gut is a highly vulnerable tissue, susceptible to infections.
- Indicate the development of the immune system, including the function of lymphocytes
- Identify patients at risk of immunodeficiency (CSP3)
- Understand cytokines and their function (FM1)
- To understand how the immune system can sometimes do more harm than good
- Indicate the development of the immune system, including the function of lymphocytes. (GEP/HD, HD1)
- 1. To understand that immunology is related to disease including infections, autoimmunity and allergy (hypersensitivity). (FM1)
- Appreciate the key concept that cytokines are very beneficial molecules in small localised controlled doses, but are extremely harmful molecules in high prolonged and systemic doses (FM1)
- Realise that only a single layer of epithelium separates the gut lumen from the tissues.
- To understand that the immune response normally can tell the difference between ‘self’ and ‘non-self’
- Be aware of the main players in the immune system including lymphocytes (T-cells, B cells and NK cells), myeloid cells (macrophages and granulocytes), dendritic cells and antibodies (FM1)
- Identify clinical features suggestive of deficiency of Non-specific defences; Neutrophils; Antibody; T-Lymphocytes ('combined') deficiencies (CSP3)
- Appreciate that the gut contains the majority of the immune system in the body
- Know that the immune system is an agent of harm in the modern age (FM1)
- Appreciate that communication between cells is critical (FM1)
- To give examples in which this ability to discriminate breaks down - autoimmunity
- Understand principles of management of immune deficient patients (CSP3)
- To understand that an appropriate immune response is sometimes undesirable, such as in transplantation
- IgA is the secretory immunoglobulin
- Realise the importance of long term immunological memory (FM1)
- List features of the following primary immunodeficiency syndromes: Common variable immune deficiency, X-linked agammaglobulinaemia, Di George syndrome, Severe combined immune deficiency, chronic granulomatous disease, Classical complement pathway deficiency, Lytic sequence deficiencies, Chediak-Higashi syndrome, Wiskott-Aldrich syndrome. (CSP3)
- Explain the immunological processes enabling protection against disease to take place. (GEP/HD, HD1)
- Distinguish the features of the following conditions: conjunctivitis/rhinitis/sinusitis, asthma, atopic dermatitis, aspirin sensitivity, oral allergy syndrome, other food allergy, latex allergy, drug allergy, erythema multiforme and Stevens-Johnson syndrome (CSP3)
- To be aware of the basic therapeutic mechanisms by which we deliberately suppress the immune system in auto-immunity and transplantation.
- List the features of the following secondary immunodeficiency syndromes: neutropenia, Chronic lymphocytic leukaemia, splenectomy, AIDS, Immunodeficiency due to immunosuppression. (CSP3)
- Match these tests to their diagnostic indications: total IgE, specific IgE, tryptase, C3, C4, C1q, C2, anti-C1q antibodies, D-dimers, C1 esterase inhibitor, cryoglobulins, skin-prick tests, patch tests (CSP3)
- While the gut epithelium is absorbing nutrients, it is also transporting large amounts of IgA into the gut lumen
- Absence of T cells in the gut leads to chronic low grade infections
- That mucosal protective immune responses are generated in Peyer's patches and expressed in lamina propria
- The Immune Response in Health
- To understand the basic inflammatory processes that affect the joint in disease (GEP/M&P)
- To understand the basic immunology processes that affect the joint in disease (LOC2)
- List the physical defence barrier components of the innate immune system (skin etc), and link them with the mechanisms by which they are breached (CSP3)
- Know that many pathogens invade the spaces between cells eg extra-cellular bacteria (FM1)
- To understand the basic immunology processes that affect the joint in disease
- To appreciate the different types of inflammation in the skin - mast cell mediated, immune complex mediated, delayed-type hypersensitivity, granuloma formation. (LOC2)
- Know how bacteria are eliminated using the humoral immune response (FM1)
- To understand the basic inflammatory processes that affect the joint in disease (LOC2)
- Know what an antibody is (FM1)
- Know how phagocytes (eg neutrophils) interplay with antibodies (FM1)
- Understand complement and know its function (FM1)
- Recognition and Response to Antigens
- Understand that some pathogens live inside cells - this includes all viruses, or bacteria such as TB
- Know how the immune system recognises antigens (FM1)
- Know the meaning of the term antigen (FM1)
- How are these eliminated by the cell-mediated immune response including macrophages, cytotoxic T cells, NK cells and yd cells
- List the cellular components of the innate immune system: macrophages / monocytes; neutrophils; eosinophils; basophils / mast cells; and link them with their antigen T receptors (where known: TLRs, NOD) (CSP3)
- Understand the importance of distinguishing self from non-self (FM1)
- Introduce the idea that TCRs and BCRs are made with random antigen recognition capacities (FM1)
- Appreciate that innate immune cells recognise a limited array of microbial structures using pattern recognition receptors. (FM1)
- State how phagocytes move and kill (together with defects), and state the structures and molecules that they interact with: endothelial cells, adhesion molecules, matrix (CSP3)
- What is the MHC and its role in presenting antigens in a form that T cells can see.
- Understand how T and B cells recognise antigens and how the diversity of antigen recognition receptors on these cells is generated. (FM1)
- List the cells of the adaptive immune system (B-cells, different kinds of T-cells etc), and state the roles they play. List the different classes of antibody (CSP3)
- Be familiar with the basic structure of an antibody molecule. (FM1)
- Distinguish between Th1 and Th2 responses and list the cytokines involved in each stating the cells that secrete them (CSP3)
- Delineate the mechanism of septic shock (CSP3)
- Understand the role of antigen presentation and the structure and function of major histocompatability complex (MHC) molecules. (FM1)
- Correlate the changes in the immune system at a cellular level with the clinical consequences for the patient with HIV infection (I&I 4)
- Communication between Immune Cells and Tissues
- Know that Th1 cells drive cell-mediated immunity (FM1)
- Know that Th2 cells drive humoral immunity (FM1)
- Know that Th17 cells drive responses to extracellular bacteria (FM1)
- Know that T-reg cells retrain immune responses (FM1)
- Know that memory T-cells remember our infection history (FM1)
- Appreciate that CD4 or helper T-cells orchestrate adaptive immun responses (FM1)
- Hypersensitivity and Allergy
- Mostly revision: definitions of allergy, atopy, types of hypersensitivity, activation of mast cells, anaphylaxis, anaphylactoid reactions, scromboid and the antigens that provoke them (CSP3)
- Urticaria: description, and the different causes (allergic, infections, autoimmune, cold, cholinergic/adrenergic, physical, exercise, hormonal, haematinic deficiency) and treatment (CSP3)
- Angioedema: description, causes (allergic, inherited, acquired C1 esterase deficiency, ACE inhibitors, idiopathic) and treatment (CSP3)
- Autoimmunity
- Transplantation and Immunosupressive Therapy
- List the meanings of autograft, isograft, allograft and xenograft. (CSP3)
- Understand the role of Class 1 and Class II HLA molecules in presenting antigen to CD8 and CD4 T-lymphocytes respectively, and the ability of foreign Class I and II HLA (or xenogeneic equivalent) to directly activate some CD8 and CD4 T-lymphocytes. (CSP3)
- Understand and know the timing of the terms: Hyperacute rejection (mediated by antibodies against Graft HLA molecules + complement), Accelerated rejection (mediated by presensitised T-lymphocytes), Acute rejection mediated by T-lymphcytes, and chronic rejection (uncertain mechanisms). (CSP3)
- Know the role of IL2 and IFNy in promoting T-lymphocyte reactivity, and of IL4 and 6 in producing anti-graft antibodies. (CSP3)
- Understand the role of recipient antibody screening, and of cross matching in prevention of hyper-acute rejection. (CSP3)
- Understand that bone marrow transplant carries the additional risk of Graft-versus-Host. (CSP3)
- Immunology - Neurological Diseases
- Immunology - Respiratory Disease
- Explain the two phases of asthma and how bronchial hyper-responsiveness is documented (CSP3)
- Explain the role of mast cells, eosinophils, dendritic cells, B lymphocytes and CD4 Th1 and CD4 Th2 T-lymphocytes in asthma (CSP3)
- Explain the role of IgE, Fcel1, FceRII, IL2, IL3, IL4, IL5, IL13, GMCSF gamma interferon, histamine, leukotrienes, cytokines, adhesion molecules and the Th1/Th2 paradigm (CSP3)
- List environmental and genetic factors predisposing to or protecting from asthma (CSP3)
- Immunology - Renal Diseases
- Describe the MHC / HLA system and its role in the immune response
- Describe the role of T-cells and B-cells in the immune response
- Describe the complications associated with anti-rejection therapy
- Be aware of the concept of rapidly progressive glomerulonephritis and the relevant autoantibodies ie anti-GBM and ANCA and their association with pulmonary haemorrhage
- Immunology - Dermatological Disease
- Immunology - General Outcomes
- Inflammation